OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 64 filers reported holding OVID THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $50,000 | -15.3% | 14,932 | -0.7% | 0.00% | – |
| Q2 2021 | $59,000 | -3.3% | 15,032 | -0.3% | 0.00% | – |
| Q1 2021 | $61,000 | +74.3% | 15,082 | +0.7% | 0.00% | – |
| Q4 2020 | $35,000 | -59.3% | 14,982 | 0.0% | 0.00% | – |
| Q3 2020 | $86,000 | -32.3% | 14,982 | -13.1% | 0.00% | – |
| Q2 2020 | $127,000 | +176.1% | 17,232 | +10.9% | 0.00% | – |
| Q1 2020 | $46,000 | -28.1% | 15,532 | 0.0% | 0.00% | – |
| Q4 2019 | $64,000 | +33.3% | 15,532 | +4.0% | 0.00% | – |
| Q3 2019 | $48,000 | +71.4% | 14,932 | 0.0% | 0.00% | – |
| Q2 2019 | $28,000 | +7.7% | 14,932 | 0.0% | 0.00% | – |
| Q1 2019 | $26,000 | -27.8% | 14,932 | 0.0% | 0.00% | – |
| Q4 2018 | $36,000 | -57.6% | 14,932 | 0.0% | 0.00% | – |
| Q3 2018 | $85,000 | -26.7% | 14,932 | 0.0% | 0.00% | – |
| Q2 2018 | $116,000 | +9.4% | 14,932 | 0.0% | 0.00% | – |
| Q1 2018 | $106,000 | – | 14,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
| BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
| EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
| GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
| Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
| CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
| Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
| DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
| Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
| XTX Topco Ltd | 50,569 | $198,000 | 0.07% |